Bound Therapeutics is a pioneering biotechnology company dedicated to the development of RNA-based therapies targeting rare and refractory diseases, with a primary focus on oncology. Our proprietary platform, Magic Bullet Designer (MBD), utilizes advanced artificial intelligence and machine learning algorithms to optimize the tissue-specific delivery of RNA therapeutics, thereby enhancing precision and therapeutic efficacy. Currently in the preclinical stage, our pipeline encompasses novel treatments for aggressive malignancies and genetic disorders, positioning Bound Therapeutics at the forefront of next-generation RNA therapeutics.